GENE EXPRESSION INDICES ASSOCIATED WITH CHEMORESISTANCE
GENE EXPRESSION INDICES ASSOCIATED WITH CHEMORESISTANCE
批准号:
6342159
负责人:
James C. Willey
金额:
$10.8万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-01-06 至 2001-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Abstract) Non-small cell lung cancer (NSCLC) is
poorly responsive to current chemotherapeutic regimens with an overall
regression rate of only 30-50%. The mechanisms of resistance are likely to
involve multiple gene products. In preliminary studies the H1435 non-small cell
lung cancer (NSCLC) cell line is 50-fold more resistant to carboplatin than
H460. Evaluation of 20 genes putatively associated with chemoresistance
revealed that glutathione transferase (GST) P1, Bax alpha, GADD45, ERCC3, and
glutathione peroxidase, mGST genes are expressed at 100, 20, 10, 6, 5, and
4-fold higher levels respectively in H1435. The primary long term objective of
the proposed investigation is to improve mechanistic understanding of NSCLC
chemoresistance and to develop a method for predicting which NSCLC tumors will
respond to carboplatin. Achieving these goals will have specific value by 1)
allowing development of improved chemotherapeutic agents based on a knowledge
of mechanisms, 2) sparing patients with carboplatin resistant tumors
unnecessary suffering and expense by avoiding an ineffective treatment, 3)
allowing patients with carboplatin resistant tumors to pursue alternative
treatment options without delay, and 4) providing a general model for
identifying tumors resistant to other chemotherapeutic regimens. To achieve
these goals, many genes must be evaluated. Carcinoma cell lines will be the
most appropriate model for a comprehensive investigation. The specific aims are
the following. Aim 1) Determine expression of eighty putative carboplatin
chemoresistance genes in ten NSCLC lines, determine the IC30 concentration of
carboplatin for each line, then determine which constitutive expression
patterns correlate best statistically (by linear regression or by Duncan's
Multiple Range test) with resistance. Any correlation identified will be
validated in ten additional NSCLC lines. Aim 2) Combine the individual
constitutive gene expression values into indices and assess them for
association with the initial ten chemoresistant cell lines. Any correlation
will be validated in the second ten lines. The competitive template RT-PCR gene
expression quantification method proposed for this project is suggested by the
applicant to be the best available because 1) it allows high throughput
measurement of many samples. 2) the data produced are in standard units so that
individual gene expression values may be combined mathematically in gene
expression indices, and 3) because the same standard mixture of competitive
templates will be used for all of the proposed experiments, data from all
experiments may be compared for statistical analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inherited genetic risk factors common to COPD and lung cancer.
-
批准号:8666031
-
项目类别:
-
资助金额:$39.62万
-
财政年份:2011
-
负责人:James C. Willey
-
依托单位:
Inherited genetic risk factors common to COPD and lung cancer.
-
批准号:8286162
-
项目类别:
-
资助金额:$46.56万
-
财政年份:2011
-
负责人:James C. Willey
-
依托单位:
Inherited genetic risk factors common to COPD and lung cancer.
-
批准号:8471176
-
项目类别:
-
资助金额:$46.6万
-
财政年份:2011
-
负责人:James C. Willey
-
依托单位:
Inherited genetic risk factors common to COPD and lung cancer.
-
批准号:8099252
-
项目类别:
-
资助金额:$55.19万
-
财政年份:2011
-
负责人:James C. Willey
-
依托单位:
Implementation of innovative RNA sample quality control methods
-
批准号:8043645
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2010
-
负责人:James C. Willey
-
依托单位:
Validation of a multi-gene test for lung cancer risk
-
批准号:7861753
-
项目类别:
-
资助金额:$79.94万
-
财政年份:2009
-
负责人:James C. Willey
-
依托单位:
Validation of a multi-gene test for lung cancer risk
-
批准号:7944175
-
项目类别:
-
资助金额:$85.04万
-
财政年份:2009
-
负责人:James C. Willey
-
依托单位:
Standardized NanoArray PCR for Gene Expression Profiling of Lung Cancer
-
批准号:8005977
-
项目类别:
-
资助金额:$15.38万
-
财政年份:2008
-
负责人:James C. Willey
-
依托单位:
Lung Cancer Diagnostic Test Validation in FNA Specimens
-
批准号:6762040
-
项目类别:
-
资助金额:$14.27万
-
财政年份:2004
-
负责人:James C. Willey
-
依托单位:
Standardized Gene Expression Core Facility Development
-
批准号:6747345
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2002
-
负责人:James C. Willey
-
依托单位:
Standardized Gene Expression Core Facility Development
-
批准号:6878572
-
项目类别:
-
资助金额:$16.51万
-
财政年份:2002
-
负责人:James C. Willey
-
依托单位:
Standardized Gene Expression Core Facility Development
-
批准号:6624375
-
项目类别:
-
资助金额:$19.97万
-
财政年份:2002
-
负责人:James C. Willey
-
依托单位:
Standardized Gene Expression Core Facility Development
-
批准号:7066600
-
项目类别:
-
资助金额:$16.55万
-
财政年份:2002
-
负责人:James C. Willey
-
依托单位:
Standardized Gene Expression Core Facility Development
-
批准号:6474280
-
项目类别:
-
资助金额:$22.48万
-
财政年份:2002
-
负责人:James C. Willey
-
依托单位:
GENE EXPRESSION INDICES ASSOCIATED WITH CHEMORESISTANCE
-
批准号:6044383
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2000
-
负责人:James C. Willey
-
依托单位:
CORE--HUMAN CELL AND TISSUE ACQUISITION
-
批准号:6338780
-
项目类别:
-
资助金额:$22.21万
-
财政年份:2000
-
负责人:James C. Willey
-
依托单位:
CORE--HUMAN CELL AND TISSUE ACQUISITION
-
批准号:6106417
-
项目类别:
-
资助金额:$22.21万
-
财政年份:1999
-
负责人:James C. Willey
-
依托单位:
GENE EXPRESSION INDICES IN CHEMORESISTANT LUNG CANCER
-
批准号:6077659
-
项目类别:
-
资助金额:$10.61万
-
财政年份:1999
-
负责人:James C. Willey
-
依托单位:
GENE EXPRESSION INDICES IN CHEMORESISTANT LUNG CANCER
-
批准号:6514368
-
项目类别:
-
资助金额:$20.23万
-
财政年份:1999
-
负责人:James C. Willey
-
依托单位:
GENE EXPRESSION INDICES IN CHEMORESISTANT LUNG CANCER
-
批准号:6633621
-
项目类别:
-
资助金额:$20.84万
-
财政年份:1999
-
负责人:James C. Willey
-
依托单位:
海外基金